Development of an Interactive Digital Respiratory Game and Device and Investigation of Its Effectiveness in Children With Bronchiectasis
1 other identifier
interventional
40
1 country
1
Brief Summary
Our study aims to develop a personalized interactive digital breathing game and device that can be produced in our country and to provide daily airway cleaning treatment at home via mobile phone or computer without the need for a physiotherapist or healthcare professional with the use of an interactive digital breathing game.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2024
CompletedFirst Posted
Study publicly available on registry
March 27, 2025
CompletedStudy Start
First participant enrolled
October 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2026
CompletedJanuary 6, 2026
January 1, 2026
2 months
September 18, 2024
January 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
6 Minute Walk Test
6MWT is defined as a submaximal test that can be easily applied in healthy or unhealthy individuals and is evaluated as an indicator of exercise capacity and walking capacity as well as many cardiovascular diseases. The 6MWT is referred to as the "Gold Standard" test of walking capacity. The aim of this test is to reach the longest possible walking distance at the end of six minutes. The standard protocol is applied in a 30-meter uninterrupted corridor or open area. It is recommended to repeat the 6MWT three times on the same day with a one-hour rest interval; the maximum walking distance is taken into account.
baseline and within 1 week after intervention
Evaluation of Expiratory Muscle Strength
Inspiratory and expiratory respiratory muscle strength will be evaluated by measuring maximal mouth pressure. Maximal mouth pressure will be measured using the Micro RPM brand (Micro Medical; England) portable electronic mouth pressure measurement device, in accordance with ATS/ERS criteria. Maximal expiratory pressure (MEP) will be measured to assess expiratory muscle strength.
baseline and within 1 week after intervention
Evaluation of Inspiratory Muscle Strength
Inspiratory and expiratory respiratory muscle strength will be evaluated by measuring maximal mouth pressure. Maximal mouth pressure will be measured using the Micro RPM brand (Micro Medical; England) portable electronic mouth pressure measurement device, in accordance with ATS/ERS criteria. Maximal inspiratory pressure (MIP) will be measured to assess inspiratory muscle strength,.
baseline and within 1 week after intervention
Secondary Outcomes (8)
Evaluation of Quality of Life
baseline and within 1 week after intervention
Evaluation of Cough
baseline and within 1 week after intervention
Assessment of Sleep Quality
baseline and within 1 week after intervention
Evaluation of Peripheral Muscle Strength
baseline and within 1 week after intervention
Respiratory Function Test- FEV1 value
baseline and within 1 week after intervention
- +3 more secondary outcomes
Other Outcomes (1)
Evaluation of Participation in the Program
baseline and within 1 week after intervention
Study Arms (2)
Breathing Game Group
EXPERIMENTALThe participants will perform the interactive digital game.
Control Group
ACTIVE COMPARATORThe participants will perform home based exercise
Interventions
Patients in the home-based exercise training group will be asked to perform the active breathing techniques cycle, which is an airway clearance technique, twice a day, 7 days a week, for 20 minutes each, for 8 weeks and to follow the program that includes physical activity recommendations. Patients who use mucolytic and/or nebulized drugs such as hypertonic saline or mannitol will be instructed to perform nebulization before performing the active breathing techniques cycle.
With the development of technology and digitalization, Digital Respiratory Games (DRG) offer an alternative solution. DRGs, with their difficulty levels, provide a platform for progression, offering a fun and engaging experience that enhances patient adherence to therapy through storytelling and user interaction. The absence of a locally made DRG in Turkey, despite the chronic respiratory diseases impact, has led to the need for an interactive DRG with personalized features. The developed interactive DRG and device will be Turkey first interactive DRG example, designed to respond to different respiratory maneuvers. The developed DRG and device will detect the lung volume and flow rates and allow for the real-time execution of maneuvers within the Active Cycle of Breathing Techniques (ACBT) in a playful environment.
Eligibility Criteria
You may qualify if:
- Aged between 7-18 years
- Clinically stable
- No exacerbations or infections
- Possesses a computer, tablet, or mobile phone
You may not qualify if:
- Participation in a supervised physiotherapy and rehabilitation program within the last 6 months
- History of lung or liver transplant
- Presence of any cognitive impairment that would hinder the use of the system
- Changes in medical treatment during the study
- Presence of concurrent cardiac, orthopedic, or neurological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Atlas Universitylead
Study Sites (1)
Istanbul Atlas University
Istanbul, 34000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
September 18, 2024
First Posted
March 27, 2025
Study Start
October 7, 2025
Primary Completion
December 7, 2025
Study Completion
January 15, 2026
Last Updated
January 6, 2026
Record last verified: 2026-01